IOL Chemicals And PharmaceuticalsNSE:IOLCP -4.89%63 5-Year Yield-on-Cost % is 0.68 as of Jul. 04, 2026, which is 35% below its 10-year median of 1.04. GuruFocus rates NSE:IOLCP with a GF Score™ of 63/100 and a GF Value™ of ₹93.85 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 517 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks worse than 76.98% on this metric.
The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:IOLCP'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.37 Med: 1.04 Max: 1.96
Current: 0.68
During the past 13 years, IOL Chemicals And Pharmaceuticals's highest Yield on Cost was 1.96. The lowest was 0.37. And the median was 1.04.
NSE:IOLCP's 5-Year Yield-on-Cost % is ranked worse than 76.98% of 517
companies
in the Drug Manufacturers industry
Industry Median: 2.34
vs NSE:IOLCP: 0.68
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
IOL Chemicals And Pharmaceuticals 5-Year Yield-on-Cost % Related Terms
NSE:IOLCP vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's 5-Year Yield-on-Cost % falls into.
IOL Chemicals And Pharmaceuticals 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a 5-Year Yield-on-Cost % of 0.68 as of Jul. 04, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 35% below median its historical median of 1.04. Over the past decade, IOL Chemicals And Pharmaceuticals' 5-Year Yield-on-Cost % has ranged from 0.37 to 1.96. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #398 out of 517 companies in the Drug Manufacturers industry, placing it in the top 77%.
Is IOL Chemicals And Pharmaceuticals' 5-Year Yield-on-Cost % too high?
IOL Chemicals And Pharmaceuticals' current 5-Year Yield-on-Cost % of 0.68 is 35% below median its 10-year median of 1.04. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 1.96. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.34. IOL Chemicals And Pharmaceuticals' value of 0.68 is 70.9% below this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #398 out of 517 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #398 out of 517 companies for 5-Year Yield-on-Cost %. This places IOL Chemicals And Pharmaceuticals in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.34. IOL Chemicals And Pharmaceuticals' value of 0.68 is 70.9% below this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own 5-Year Yield-on-Cost % has ranged from 0.37 to 1.96 over the past decade. While the company's 10-year median is 1.04 vs. the industry median of 2.34, IOL Chemicals And Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.34, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current 5-Year Yield-on-Cost % of 0.68 is 70.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current 5-Year Yield-on-Cost % is 0.68, which is 35% below median its own 10-year median of 1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.85, compared to a current price of ₹142.96 — trading 52.3% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.68, which is 35% below median its 10-year median of 1.04 and 70.9% below the Drug Manufacturers industry median of 2.34. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current 5-Year Yield-on-Cost % is 0.68 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹142.96 is trading 52.3% above its estimated GF Value™ of ₹93.85.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
5-Year Yield-on-Cost %: 0.68 (35% below median its 10-year median of 1.04)
GF Value™: ₹93.85 vs. price of ₹142.96 (52.3% above fair value)
Industry Position: 70.9% below the Drug Manufacturers median (#398 of 517)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Business Description
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
63GF Score
Get the complete analysis for NSE:IOLCP
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 